scispace - formally typeset
Y

Yiming Lin

Researcher at Zhejiang University

Publications -  16
Citations -  4178

Yiming Lin is an academic researcher from Zhejiang University. The author has contributed to research in topics: Nonalcoholic fatty liver disease & Medicine. The author has an hindex of 8, co-authored 12 publications receiving 2003 citations.

Papers
More filters
Journal ArticleDOI

Retrospective study: The diagnostic accuracy of conventional forceps biopsy of gastric epithelial compared to endoscopic submucosal dissection (STROBE compliant).

TL;DR: According to the analysis, old men plus gastric fundus or antrum of CFB were strongly suggested to perform ESD if precancerous lesions were found and young women with low-grade intraepithelial neoplasia could select regular follow-up.
Journal ArticleDOI

Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism

TL;DR: It is found that uric acid directly induces hepatocyte fat accumulation, insulin resistance, and insulin signaling impairment both in vivo and in vitro, and may be a new therapeutic target for NAFLD and insulin resistance.
Journal ArticleDOI

Relaxor-like dielectric behavior in La2NiMnO6 double perovskite ceramics

TL;DR: In this paper, the dielectric and conductive properties of double perovskite ceramics were investigated together with the crystal structure, and they were well fitted by the modified Debye equation and Arrhenius law with the activation energy of 0.17 eV.
Journal ArticleDOI

Fatty acids promote fatty liver disease via the dysregulation of 3-mercaptopyruvate sulfurtransferase/hydrogen sulfide pathway

TL;DR: Investigation of the underlying mechanisms by which FFA contributes to the pathogenesis of NAFLD via the regulation of 3-mercaptopyruvate sulfurtransferase (MPST), a key enzyme that regulates endogenous hydrogen sulfide (H2S) biosynthesis, found that FFAs upregulate hepatic expression of MPST and subsequently inhibit the CSE/ H2S pathway, leading to NA FLD.
Journal ArticleDOI

Probiotic supplementation does not improve eradication rate of Helicobacter pylori infection compared to placebo based on standard therapy: a meta-analysis.

TL;DR: The pooled data suggest that the use of probiotics plus standard therapy does not improve the eradication rate of H. pylori infection compared to the placebo, and probiotics did improve the adverse effects of diarrhea and nausea.